Medi-Weightloss vs VivioMD

Shoppers near one of Medi-Weightloss's 139 US clinics who want in-person labs and are comfortable with location-dependent pricing.

Reasons to consider it

• +The homepage reports 139 in-person clinic locations across the US, with labs and body composition analysis done at the new-patient visit
• +Publishes real introductory numbers ($99 semaglutide / $199 tirzepatide first month) rather than staying fully opaque
• +Insurance path available for branded Zepbound/Wegovy/Saxenda, with the site claiming most insured patients 'pay between $0 and $50 per visit'

What to weigh up

• −The $99/$199 headline figures are explicitly FIRST-MONTH-ONLY; the ongoing self-pay rate 'varies by program and location' and is never published anywhere on the site
• −A separate $199 new-patient visit fee is charged before the first month's medication price even applies
• −Because each clinic is independently operated, the same program can cost a different amount at two different Medi-Weightloss locations

Shoppers who want both compounded and FDA-approved GLP-1 options from one nationwide platform, and don't mind completing an intake before seeing price.

Reasons to consider it

• +Offers branded and compounded treatment paths
• +Names OpenLoop as a clinical partner
• +Provider messaging and follow-up support

What to weigh up

• −No public medication price before assessment
• −Current terms do not identify the dispensing pharmacies
• −No medical director is named

Regulatory note: the FDA issued a warning letter to VivioMD Group LLC dba VivioMD in June 2026. We still list and link to VivioMD; you should know the letter is on the public record before you decide.